To clarify the functional role of PAK6 in chemotherapy, we used an shRNA-based strategy to stably downregulate PAK6 in colon cancer cells that express high levels of the protein, and overexpressed PAK6 in colon cancer cells that express low levels of the protein. The gene discussed is PAK6; the disease is colonic neoplasm.